clinical trial · NCT07307794
To Evaluate the Adhesion of TK-254RX on Healthy Participants
Teikoku Seiyaku Co., Ltd.·phase1·recruiting·n = 90
Healthy ParticipantsEsflurbiprofen Topical System
brief summary
This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.
started
Jan 19, 2026
primary completion
Mar 1, 2026
completion
Mar 1, 2026
last updated
Jan 28, 2026
official title
Characterisation of Adhesion Performance of a Newly Developed Esflurbiprofen Topical System (EFTS) - a Phase I, Open-label Study in Healthy Subjects.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol